The tumor microenvironment (TME) also presents a significant barrier to CAR-NK cell efficacy, as immunosuppressive cytokines such as TGF-β can reduce the expression of activating receptors and suppress IFN-γ production by NK cells. Here, IFNG is linked to neoplasm.